Vinicius Ricardo Cuña de Souza

Vinicius Ricardo Cuña de Souza

Auto-generated profile, based on publicly available information

Vinicius Ricardo Cuña de Souza

Centro Universitário de Lisboa, Portugal

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2012 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
LFLeonardo Farias
Leonardo Farias
DSDunia Del Carmen Rodriguez Soto
Dunia Del Carmen Rodriguez Soto
VCVinicius Cunna
Vinicius Cunna
HRHenrique Krambeck Rofatto
Henrique Krambeck Rofatto
EFEliana L. Faquim-Mauro
Eliana L. Faquim-Mauro
LLLuciana C. C. Leite
Luciana C. C. Leite
The Schistosoma mansoni Venom-Allergen-Like proteins (SmVALs) are members of the SCP/TAPS (Sperm-coating protein/Tpx-1/Ag5/PR-1/Sc7) protein superfamily, which may be important in the host-pathogen interaction. Some of these molecules were suggested by us and others as potential immunomodulators and vaccine candidates, due to their functional classification, expression profile and predicted localization. From a vaccine perspective, one of the concerns is the potential allergic effect of these molecules. Herein, we characterized the putative secreted proteins SmVAL4 and SmVAL26 and explored the mouse model of airway inflammation to investigate their potential allergenic properties. The respective recombinant proteins were obtained in the Pichia pastoris system and the purified proteins used to produce specific antibodies. SmVAL4 protein was revealed to be present only in the cercarial stage, increasing from 0–6 h in the secretions of newly transformed schistosomulum. SmVAL26 was identified only in the egg stage, mainly in the hatched eggs' fluid and also in the secretions of cultured eggs. Concerning the investigation of the allergic properties of these proteins in the mouse model of airway inflammation, SmVAL4 induced a significant increase in total cells in the bronchoalveolar lavage fluid, mostly due to an increase in eosinophils and macrophages, which correlated with increases in IgG1, IgE and IL-5, characterizing a typical allergic airway inflammation response. High titers of anaphylactic IgG1 were revealed by the Passive Cutaneous Anaphylactic (PCA) hypersensitivity assay. Additionally, in a more conventional protocol of immunization for vaccine trials, rSmVAL4 still induced high levels of IgG1 and IgE. Our results suggest that members of the SmVAL family do present allergic properties; however, this varies significantly and therefore should be considered in the design of a schistosomiasis vaccine. Additionally, the murine model of airway inflammation proved to be useful in the investigation of allergic properties of potential vaccine candidates. The Schistosoma mansoni Venom Allergen Like proteins (SmVALs) have been identified in the Transcriptome and Post-Genomic studies as targets for immune interventions. Two secreted members of the family were obtained as recombinant proteins in the native conformation. Antibodies produced against them showed that SmVAL4 was present mostly in cercarial secretions and SmVAL26 in egg secretions and that only the native SmVAL4 contained carbohydrate moieties. Due to concerns with potential allergic characteristics of this class of molecules, we have explored the mouse model of airway inflammation in order to investigate these properties in a more confined system. Sensitization and challenge with rSmVAL4, but not rSmVAL26, induced extensive migration of cells to the lungs, mostly eosinophils and macrophages; moreover, immunological parameters were also characteristic of an allergic inflammatory response. Our results showed that the allergic potential of this class of proteins can be variable and that the vaccine candidates should be characterized; the mouse model of airway inflammation can be useful to evaluate these properties.

19 May 2017 in Brazilian Journal of Veterinary Research and Animal Science
Verified
Journal Article
Open access
PDF file
AAAnderson Luiz Araujo
Anderson Luiz Araujo
FTFernanda Almeida Teixeira
Fernanda Almeida Teixeira
TLTracy Ferreira Lacerda
Tracy Ferreira Lacerda
MFMayra Cunha Flecher
Mayra Cunha Flecher
VSVinicius Ricardo Cuña Souza
Vinicius Ricardo Cuña Souza
CCClarisse S. Coelho
Clarisse S. Coelho
Este trabalho realizou uma avaliação clínica e histopatológica da aplicação tópica do óleo de andiroba (Carapa guianensis Aublet), puro e ozonizado, no processo de cicatrização de feridas em cinco equinos saudáveis. Oito feridas de 6,25 cm2 foram induzidas cirurgicamente, quatro de cada lado da região lombar, craniais em relação à região sacral. Em três animais, o lado esquerdo foi destinado à avaliação macroscópica e mensuração de área, enquanto o lado direito foi destinado à análise histopatológica. Nos outros dois animais, as avaliações foram invertidas. O tratamento tópico foi iniciado 12 horas após a indução cirúrgica e foi mantido diariamente até a completa cicatrização das feridas. Foram usados, sequencialmente e bilateralmente, no sentido craniocaudal: solução salina (GC), solução salina ozonizada (GO), óleo de andiroba puro (GAP) e óleo de andiroba ozonizado (GAO). Aleatoriamente, a sequência de tratamentos foi modificada. As análises macroscópicas e microscópicas foram realizadas 3, 7, 14 e 21 dias após a cirurgia, e o tempo total para cicatrização registrado. A contração da ferida foi de 67,75% para GC, 65,26% para GO, 67,91% para GAP, e 69,84% para GAO. A avaliação histopatológica demonstrou que as feridas tratadas com GAO e GAP apresentaram uma avançada epitelização, proliferação fibroblástica e deposição de colágeno, moderada proliferação vascular e presença de infiltrados de células polimorfonucleares (PMN) e discreta proliferação de células mononucleares (MN). Foi possível concluir que todos os tratamentos usados foram benéficos perante o grupo de controle, mostrando que as versões pura e ozonizada do óleo de andiroba representam alternativas terapêuticas ao tratamento de feridas em equinos.

11 June 2013 in Brazilian Journal of Veterinary Research and Animal Science
Verified
Journal Article
Open access
PDF file
JGJuliana Almeida Nogueira da Gama
Juliana Almeida Nogueira da Gama
MSMeryelli Sales de Souza
Meryelli Sales de Souza
ENEvandro Pereira Neto
Evandro Pereira Neto
VSVinicius Ricardo Cuña de Souza
Vinicius Ricardo Cuña de Souza
CCClarisse S. Coelho
Clarisse S. Coelho
Concentrações séricas de aspartato aminotransferase e creatinoquinase e concentrações plasmáticas de lactato em equinos da raça Mangalarga Marchador após exercício físico

1 August 2019 in Journal of Equine Veterinary Science
Verified
Journal Article
Closed access
CCClarisse S. Coelho
Clarisse S. Coelho
GAGustavo Luiz Adam
Gustavo Luiz Adam
GSGabriella Agra de Omena e Silva
Gabriella Agra de Omena e Silva
RCRenan Silva de Carvalho
Renan Silva de Carvalho
VSVinicius Ricardo Cuña de Souza
Vinicius Ricardo Cuña de Souza
Francesco FazioFrancesco Fazio
Francesco Fazio

30 May 2024 in Antioxidants
Verified
Journal Article
Open access
PDF file
LSLaís Pereira Silva
Laís Pereira Silva
RPRicardo Portela
Ricardo Portela
MMMarília Carneiro Machado
Marília Carneiro Machado
Gisele André Baptista CanutoGisele André Baptista Canuto
Gisele André Baptista Canuto
JNJoão Moreira Costa Neto
João Moreira Costa Neto
ALAlessandra Lima
Alessandra Lima
Considering the high frequency of malignant breast tumors, there is a growing search for new therapeutic strategies that control neoplastic growth and dissemination, combined with fewer adverse reactions. Therefore, this study evaluated the effects of ozone therapy in female dogs with mammary cancer undergoing chemotherapy treatment. Twenty-five canines diagnosed with malignant mammary neoplasia were divided into two groups: one treated with carboplatin alone (n = 11) and the other with carboplatin associated with ozone therapy (n = 14). Clinical and laboratory evaluations, mastectomy, analysis of the oxidative profile based on total antioxidant capacity (TAC) and serum concentrations of malondialdehyde (MDA), survival rate, and quality of life were performed. Animals in the ozone therapy group had higher concentrations of red blood cells and platelets, significantly improving the survival rate and quality of life. Furthermore, adverse reactions were less intense and frequent in this group, which was associated with an increase in TAC and a reduction in MDA. These results indicate that the combination of carboplatin and ozone therapy represents a promising complementary treatment for female dogs with mammary cancer, as it was associated with fewer adverse reactions and a better oxidative profile.

1 January 2004 in Experimental Lung Research
Verified
Journal Article
Closed access
OROrlando Garcia Ribeiro
Orlando Garcia Ribeiro
WCWafa Hanna Cabrera
Wafa Hanna Cabrera
DMDurvanei Augusto Maria
Durvanei Augusto Maria
MFMarcelo De Franco
Marcelo De Franco
SMSolange Massa
Solange Massa
OIOlga Martinez Ibañez
Olga Martinez Ibañez
Mice selected for a high acute inflammatory response (AIRmax) are resistant to chemically induced lung tumorigenesis, whereas the low responders (AIRmin) are susceptible. In urethane-treated mice, anti-inflammatory drugs increased the tumor incidence in AIRmax but not AIRmin mice, and an inverse correlation (P<.001) between the degree of acute inflammatory response (AIR) and lung tumorigenesis was found in an F2 (AIRmax×AIRmin) intercross population. The results provide evidence for the involvement of lung tumor modifier loci in AIR regulation and implicate AIR quantitative trait loci in the inherited predisposition to lung cancer.